Recombinant Human PSMC2 Protein，His

PSMC2, also known as Proteasome 26S Subunit, ATPase 2, is a vital component of the 26S proteasome complex, which plays a crucial role in protein degradation and the regulation of various cellular processes, including the cell cycle, apoptosis, and signaling pathways. The proteasome functions by recognizing ubiquitin-tagged proteins and facilitating their ATP-dependent degradation, thereby maintaining cellular homeostasis. Research into PSMC2 has gained prominence due to its involvement in several disease states, including cancer, neurodegenerative disorders, and viral infections. It has been identified as a potential therapeutic target because of its role in regulating the turnover of both oncogenic and tumor suppressor proteins. Moreover, recent studies have shown that PSMC2 may influence the efficacy of certain chemotherapeutic agents, highlighting its importance in cancer treatment strategies. Understanding the structure and function of PSMC2, as well as its interaction with other subunits within the proteasome, is critical for developing novel interventions that could enhance the effectiveness of existing therapies or lead to the creation of new ones. Given these factors, ongoing research focuses on characterizing the recombinant PSMC2 protein to elucidate its mechanisms of action, explore its interactions with potential inhibitors, and assess its role in disease progression, which could pave the way for innovative therapeutic approaches using targeted proteasome modulation.